DSpace at RU >

Browsing by Author Holt, B. van der

Full Text	Issue Date	Title	Author(s)
	2011	Dextromethorphan as a phenotyping test to predict endoxifen exposure in patients on tamoxifen treatment	Graan, A.J. de; Teunissen, S.F.; Vos, F.Y. de; Loos, W.J.; Schaik, R.H. van, et al
	2011	Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40	Rijneveld, A.W.; Holt, B. van der; Daenen, S.M.G.J.; Biemond, B.J.; Weerdt, O. de, et al
	2011	Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia	Lodewyck, T.; Oudshoorn, M.; Holt, B. van der; Petersen, E.; Spierings, E., et al
	2011	First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response	Taal, W.; Dubbink, H.J.; Zonnenberg, C.B.; Zonnenberg, B.A.; Postma, T.J.B.M., et al
	2010	Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients.	Broyl, A.; Hose, D.; Lokhorst, H.; Knegt, Y. de; Peeters, J., et al
	2010	Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia.	Deenik, W.; Janssen, J.J.M.; Holt, B. van der; Verhoef, G.E.; Smit, W.M., et al
	2010	A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.	Lokhorst, H.M.; Holt, B. van der; Zweegman, S.; Vellenga, E.; Croockewit, S., et al
	2008	Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia.	Deenik, W.; Holt, B. van der; Verhoef, G.E.; Smit, W.M.; Kersten, M.J., et al
	2008	Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.	Lokhorst, H.M.; Schmidt-Wolf, I.; Sonneveld, P.; Holt, B. van der; Martin, H., et al
	2007	Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma : long-term follow-up of the Dutch Cooperative Group HOVON 24 trial	Sonneveld, P.; Holt, B. van der; Segeren, C.M.; Vellenga, E.; Croockewit, A.J., et al
	2007	High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia : A prospective randomized phase III study	Deenik, W.; Holt, B. van der; Verhoef, G.E.; Schattenberg, A.V.M.B.; Verdonck, L.F., et al
	2005	Splenectomy for the treatment of thrombotic thrombocytopenic purpura.	Kappers-Klunne, M.C.; Wijermans, P.W.; Fijnheer, R.; Croockewit, A.J.; Holt, B. van der, et al
	2005	Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.	Imhoff, G.W. van; Holt, B. van der; MacKenzie, M.A.; Veer, M.B. van 't; Wijermans, P.W., et al
	2005	Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.	Imhoff, G.W. van; Holt, B. van der; MacKenzie, M.A.; Ossenkoppele, G.J.; Wijermans, P.W., et al
	2004	The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients.	Ossenkoppele, G.J.; Graveland, W.J.; Sonneveld, P.; Daenen, S.M.G.J.; Biesma, D.H., et al